ClinicalTrials.gg
Status unknownNCT03465943Updated Mar 15, 2018

Different Preloads for Prevention of Hypotension in Patients Undergoing Elective CS Under Intrathecal Anesthesia

An Early Phase 1 interventional study of Ringer and Voluven in Hypotension Drug-Induced, sponsored by Assiut University. Status unknown. Open to female participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-03-15.

Sponsored by Assiut University · Early Phase 1, Interventional, and Prevention

How we know

The sponsor has not verified this record recently (last verified Mar 2018), so the status shown — last known as Not yet recruiting — may be out of date.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Early Phase 1
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-20

Among 16 studies in Hypotension by Assiut University — 6 open to participants now, 6 under way, 1 of them phase 3. Hypotension · Assiut University.

Planned enrollment
11th of 16
60 · median 95
Started
2018
with 2 others
Phase 1
3 of 16
none open now
Registered
5th of 16
by date

Among the 16 studies in Hypotension by Assiut University, this one is the 11th largest by planned enrollment, is one of 3 that started in 2018, is one of 3 in phase 1, and was the 5th registered.

Hypotension

893 studies on the registry are indexed under Hypotension; 197 are open to participants now.

Browse Hypotension studies →

Open to participants now

6 of the 16 studies in Hypotension by Assiut University are open now, in 1 country. Recruiting first, the newest first:

1 more — sign in →

By country, each count listing its studies:

All 6 open studies →

Where they have run

Who these studies take

Of the 112 Hypotension studies recruiting now, 51 (46%) set no upper age limit and 36 (32%) stop at 75 or younger; 7 take children under 18; 15 take healthy volunteers.

This study: 18 Years to 40 Years · female · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 16 studies in Hypotension by Assiut University, or all of them as a file.
02

Study summary

The aim of this study was to compare between crystalloid versus crystalloid and colloid combination preloads for prevention of hypotension following intrathecal anaesthesia in patients undergoing elective Caesarean section.

To examine weather baseline perfusion index could predict the incidence of intrathecal-induced hypotension during Caesarean section.

Read the detailed description

Intrathecal anesthesia is the most commonly used technique for elective Caesarean section all over the world.

One of the most common complications of this technique is hypotension. It's incidence is more than 80% without any prophylactic measures, this hypotension has adverse effects on both mother ( causing nausea and vomiting ) and foetus ( causing acidosis and neurological defects ).

This complication can be managed by several ways like fluid therapy, usage of vasopressors or combination between both of them.

Among the type of fluids ( crystalloid or colloid ) it's still not known which one of them is better. Crystalloid has a short intravascular half-life because of its rapid distribution into the interstitial space. On the other hand colloid remains longer within the intravascular space.

Change in baseline peripheral vascular tone due to pregnancy may affect the degree of such hypotension. The perfusion index ( PI ) derived from a pulse oximeter has been used for assessing peripheral perfusion dynamics due to changes in peripheral vascular tone.

03

Conditions studied

  • Hypotension Drug-Induced

Browse trials for

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age : 18-40 years
  • ASA 1\&2

Exclusion criteria

Exclusion Criteria:

  • Patients with morbid obesity.
  • Pre-existing or pregnancy-induced hypertension.
  • Known cardiovascular or cerebrovascular disease.
  • Abnormal CTG tracing.
  • Any other for intrathecal anaesthesia.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Early Phase 1
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Active comparator
    Ringer

    This group will receive 1 L of Ringer's solution as a preload

    Drug: Ringer

  • Active comparator
    Voluven

    This group will receive 500 ml of 6% hydroxyethyl starch ( Voluven ) and 500 ml Ringer's solution as a preload

    Drug: Ringer · Drug: Voluven

Interventions

06

What researchers measure

Primary outcomes

  1. Incidence of hypotension

    Decrease in systolic blood pressure more than 20% of base line

    Time frame: 1 hour

Secondary outcomes

  1. Perfusion index

    Derived from pulse oximeter

    Time frame: 1 hour

  2. Heart rate

    Time frame: 1 hour

  3. Urine output

    Time frame: 1 hour

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Ripolles Melchor J, Espinosa A, Martinez Hurtado E, Casans Frances R, Navarro Perez R, Abad Gurumeta A, Calvo Vecino JM. Colloids versus crystalloids in the prevention of hypotension induced by spinal anesthesia in elective cesarean section. A systematic review and meta-analysis. Minerva Anestesiol. 2015 Sep;81(9):1019-30. Epub 2014 Dec 11. PubMed 25501602 ↗
  • Ngan Kee WD. Confidential enquiries into maternal deaths: 50 years of closing the loop. Br J Anaesth. 2005 Apr;94(4):413-6. doi: 10.1093/bja/aei069. No abstract available. PubMed 15758080 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Mar 2018; primary completion for Mar 2019, 12 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 3, 2018
First posted
Mar 15, 2018
StartEst.
Mar 2018
Primary completionEst.
Mar 2019
CompletionEst.
Apr 2019
Last update
Mar 15, 2018
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 15, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03465943
Lead sponsor
Assiut University
Responsible party
Rafeek Ramez Shawky Aziz (Principal Investigator, Assiut University) — Principal investigator
First posted
Mar 15, 2018
Start date
Mar 2018 (estimated)
Primary completion
Mar 2019 (estimated)
Completion
Apr 2019 (estimated)
Last update
Mar 15, 2018

Study contacts

Essam E. Abd El-Hakeem, PhD
Contact
Essam1993@yahoo.com
01207159716
Nagwa Mostafa Osman, PhD
Contact
nagwaosman1962@yahoo.com
01006792219

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drug tested here: HES 130-0.4

Start the discussion